Quality assurance and the need to evaluate interventions and audit programme outcomes

Area of Science:

• Cardiology
• Healthcare Quality Improvement
• Public Health

Background:

• Evidence-based clinical guidelines are crucial for healthcare standards but face implementation challenges in practice.
• Clinical audits serve as a quality improvement tool, systematically reviewing care and driving changes to enhance patient outcomes.
• Secondary prevention in cardiovascular disease (CVD) management focuses on controlling risk factors and optimizing medical treatment.

Purpose of the Study:

• To highlight the role of clinical audits in monitoring modifiable risk factors within cardiovascular disease (CVD) management.
• To evaluate the quality improvements in CVD management achieved through clinical audit practices.
• To identify the need for more comprehensive clinical audit data, especially from low- and middle-income countries.

Main Methods:

• Systematic review of care delivery and implementation of changes through clinical audits.
• Monitoring of modifiable cardiovascular risk factors in patients with CVD.
• Analysis of existing clinical audit data to assess risk factor burden and management.

Main Results:

• Existing clinical audits offer insights into the prevalence of risk factors in CVD patients and their management.
• Current data from clinical audits are insufficient for comprehensive monitoring of quality improvement in CVD management.
• A significant lack of representative data exists from low- and middle-income countries, hindering global quality evaluation.

Conclusions:

• Clinical audits are essential for promoting quality of care and improving outcomes in cardiovascular disease (CVD) management.
• Widespread implementation of clinical audits is necessary to establish clinical standards and monitor performance.
• Enhanced data collection from clinical audits, particularly in underrepresented regions, is critical for advancing CVD care globally.